Literature DB >> 213496

Restriction endonuclease fingerprinting of herpes simplex virus DNA: a novel epidemiological tool applied to a nosocomial outbreak.

T G Buchman, B Roizman, G Adams, B H Stover.   

Abstract

In a blind study, 14 isolates of herpes simplex virus type 1 (HSV-1) that included nine isolates from a temporal cluster of HSV infections in a hospital Pediatric Intensive Care Unit and five unrelated isolates were analyzed by digestion of their DNA with four restriction endonucleases. These enzymes (HsuI, BglII, EcoRI, and HpaI) cleave the DNA in about 52 sites. To date, at least 16 sites have been found to be variable in the sense that they may be present or absent independently of any other cleavage site. This characteristic is stable, and no change was observed on serial propagation of the strains in culture or following repeated isolation, as long as 12 years apart, from humans. Analyses of the isolates readily discriminated between those belonging to the temporal cluster of hospital infections and the unrelated strains. They also showed that there were two independent introductions of HSV-1 into the Pediatric Intensive Care Unit resulting in two clusters of epidemiologically related infections. This type of analysis has the potential of becoming a powerful tool for tracing the spread of HSV-1 and very likely of other herpesviruses in the human population.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 213496     DOI: 10.1093/infdis/138.4.488

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  62 in total

Review 1.  Methods for subtyping and molecular comparison of human viral genomes.

Authors:  M Arens
Journal:  Clin Microbiol Rev       Date:  1999-10       Impact factor: 26.132

2.  Clear detection and typing of herpes simplex virus types 1 and 2 by an indirect ELISA assay: comparison with three different combined methods--capture ELISA, restriction enzymes, and polymerase chain reaction.

Authors:  P Markoulatos; P Fountoucidou; G Marinakis; V Krikelis; N Spyrou; N Vamvakopoulos; M L Moncany
Journal:  J Clin Lab Anal       Date:  1997       Impact factor: 2.352

3.  Variable R1 region in varicella zoster virus in fulminant type of acute retinal necrosis syndrome.

Authors:  T Abe; M Sato; M Tamai
Journal:  Br J Ophthalmol       Date:  2000-02       Impact factor: 4.638

4.  Origin of two different classes of defective HSV-1 Angelotti DNA.

Authors:  H C Kaerner; I B Maichle; A Ott; C H Schröder
Journal:  Nucleic Acids Res       Date:  1979-04       Impact factor: 16.971

5.  Geographical distribution of the herpes simplex virus type 1 BgKL variant in Japan suggests gradual dispersion of the virus from Shikoku Island to the other Islands.

Authors:  Shigeru Ozawa; Hiroyuki Eda; Kozaburo Hayashi; Kamesaburo Yoshino; Kazuo Yanagi
Journal:  J Clin Microbiol       Date:  2006-06       Impact factor: 5.948

6.  Homogeneity and diversity of genome polymorphism in a set of herpes simplex virus type 1 strains classified as the same genotypic group.

Authors:  K Umene; H Sakaoka
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

7.  Genotyping of herpes simplex viruses by polymerase chain reaction.

Authors:  H Piiparinen; A Vaheri
Journal:  Arch Virol       Date:  1991       Impact factor: 2.574

8.  Comparison of genomes of malignant catarrhal fever-associated herpesviruses by restriction endonuclease analysis.

Authors:  L M Shih; Y C Zee; A E Castro
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

9.  Putative glycoprotein gene of varicella-zoster virus with variable copy numbers of a 42-base-pair repeat sequence has homology to herpes simplex virus glycoprotein C.

Authors:  P R Kinchington; J Remenick; J M Ostrove; S E Straus; W T Ruyechan; J Hay
Journal:  J Virol       Date:  1986-09       Impact factor: 5.103

10.  Herpes simplex virus type 1 restriction fragment polymorphism determined using southern hybridization.

Authors:  K Umene; T Eto; R Mori; Y Takagi; L W Enquist
Journal:  Arch Virol       Date:  1984       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.